Free Trial

510,178 Shares in Xylem Inc. (NYSE:XYL) Acquired by Erste Asset Management GmbH

Xylem logo with Business Services background

Erste Asset Management GmbH acquired a new position in shares of Xylem Inc. (NYSE:XYL - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 510,178 shares of the industrial products company's stock, valued at approximately $68,593,000. Xylem accounts for about 0.8% of Erste Asset Management GmbH's investment portfolio, making the stock its 27th largest holding. Erste Asset Management GmbH owned approximately 0.21% of Xylem as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in XYL. Public Sector Pension Investment Board grew its holdings in Xylem by 12.8% during the third quarter. Public Sector Pension Investment Board now owns 10,610 shares of the industrial products company's stock valued at $1,433,000 after purchasing an additional 1,200 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Xylem by 1.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company's stock worth $465,760,000 after purchasing an additional 32,645 shares in the last quarter. Fiduciary Trust Co raised its stake in shares of Xylem by 4.5% in the 3rd quarter. Fiduciary Trust Co now owns 20,594 shares of the industrial products company's stock valued at $2,781,000 after purchasing an additional 879 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Xylem by 3.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 606,168 shares of the industrial products company's stock valued at $81,851,000 after purchasing an additional 18,347 shares in the last quarter. Finally, Providence Capital Advisors LLC boosted its position in shares of Xylem by 1.1% during the third quarter. Providence Capital Advisors LLC now owns 46,909 shares of the industrial products company's stock worth $6,334,000 after buying an additional 531 shares during the period. Institutional investors own 87.96% of the company's stock.

Xylem Price Performance

Shares of NYSE:XYL traded up $1.14 during trading on Friday, reaching $126.75. 1,083,979 shares of the company traded hands, compared to its average volume of 1,673,758. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 52 week low of $102.67 and a 52 week high of $146.08. The firm has a market capitalization of $30.79 billion, a PE ratio of 37.06, a PEG ratio of 2.33 and a beta of 1.05. The company's 50 day moving average is $129.37 and its two-hundred day moving average is $133.72.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, meeting the consensus estimate of $1.11. The company had revenue of $2.10 billion during the quarter, compared to analysts' expectations of $2.17 billion. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The business's revenue for the quarter was up .2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.99 EPS. As a group, sell-side analysts predict that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date is Tuesday, November 26th. Xylem's dividend payout ratio is presently 42.11%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on XYL. UBS Group began coverage on shares of Xylem in a report on Tuesday, August 13th. They set a "buy" rating and a $165.00 target price for the company. TD Cowen reduced their price objective on shares of Xylem from $138.00 to $125.00 and set a "hold" rating for the company in a research note on Wednesday, November 6th. Robert W. Baird lowered their target price on Xylem from $175.00 to $154.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Finally, Royal Bank of Canada reduced their price target on Xylem from $163.00 to $162.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Xylem has an average rating of "Moderate Buy" and an average target price of $149.64.

Read Our Latest Stock Report on XYL

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should you invest $1,000 in Xylem right now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines